Summary
The drugs taken by patients with suspected cutaneous drug reactions (CDR) were recorded during a 4-year period at Sahlgren Hospital in Gotenburg in a prospective study. A total of 440 patients were included. By dividing the frequency of occurrence of the recorded drugs by the number of sold defined daily doses (SDDD) for the city during the same period of time, figures for the CDR risk for different drugs corrected for frequency of use were obtained. The risk of CDR seemed to be highest for gold compounds, trimethoprim with and without sulphonamides, cephalosporins and penicillins. The most common types of CDR were macular and mucalopapular eruptions, followed by urticaria and cutaneous vasculitis. The results correlate well with those of the Boston Collaborative Drug Surveillance Program.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Arndt KA, Jick H (1976) Rates of cutaneous reactions to drugs: a report from the Boston Collaborative Drug Surveillance Program. J Am Med Assoc 235: 918–923
Bigby M, Jick S, Jick H. Arndt K (1986) Drug-induced cutaneous reactions. A report from the Boston Collaborative Drug Surveillance Program on 15 438 consecutive inpatients, 1975 to 1982. J Am Med Assoc 256: 3358–3363
Bork K (1988) Cutaneous side effects of drugs. W. B. Saunders, Philadelphia, p 8
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Swanbeck, G., Dahlberg, E. Cutaneous drug reactions. Arch Dermatol Res 284, 215–218 (1992). https://doi.org/10.1007/BF00375796
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00375796